Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career

The past 12 months

Clients
1
past 12 months
Filings
3
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATECenters For Medicare and Medicaid Services (CMS)White House Office

Specific issues

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027: Provisions related to Administration for Strategic Preparedness and Response (ASPR) mapping. FY 2027 Commerce, Justice, Science, and Related Agencies Appropriations: Provisions related to 3D-printing. FY 2027 State-Foreign Operations Appropriations: Provisions related to pharmaceutical supply chain resilience.
Budget/Appropriations · 2026 Q1
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
Health Issues · 2026 Q1
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
Budget/Appropriations · 2026 Q2
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.
Health Issues · 2026 Q2
S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.
Defense · 2026 Q2

Clients

$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings3
2026 Q1
THE UNITED STATES PHARMACOPEIAL CONVENTION
1Alda.gov →
2026 Q2
THE UNITED STATES PHARMACOPEIAL CONVENTION
Q2lda.gov →
2026 Q1
THE UNITED STATES PHARMACOPEIAL CONVENTION
Q1lda.gov →